Significant survival gains for neoadjuvant chemotherapy for high risk soft tissue sarcoma
Significant survival gains for neoadjuvant chemotherapy for high risk soft tissue sarcoma
Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial
Screening, surgical cure and new developments: Future smart surgical approaches for brain mets
NSCLC biology and new therapies: Reversing resistance
Screening, surgical cure and new developments: How to avoid false positives in lung cancer screening
Developments in checkpoint immunotherapy
Very late relapse in Hodgkins lymphoma
Modelling ponatinib resistance in BCR-ABL1 cell lines
Editor's Choice for June 2016
Results from the EURO-SKI cessation trial of TKIs in CML
Editor's ASCO 2016 Roundup
Results from SCHOLAR-1 trial for DLBCL patients